Rishi Surana, Ph.D.
Affiliations: | 2014 | Tumor Biology | Georgetown University, Washington, DC |
Area:
OncologyGoogle:
"Rishi Surana"Parents
Sign in to add mentor| Louis M. Weiner | grad student | 2014 | Georgetown | |
| (Targeting the tumor microenvironment to enhance the efficacy of tumor-targeted antibody therapy.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Surana R, Pant S. (2022) Immunotherapy in Gastrointestinal Malignancies. Advances in Experimental Medicine and Biology. 1342: 259-272 |
| Zhang YW, Nasto RE, Jablonski SA, et al. (2020) RNA interference screening methods to identify proliferation determinants and mechanisms of resistance to immune attack. Methods in Enzymology. 636: 299-322 |
| Zhang YW, Nasto RE, Jablonski SA, et al. (2017) RNA Interference Screening to Identify Proliferation Determinants in Breast Cancer Cells. Bio-Protocol. 7 |
| Murakami S, Shahbazian D, Surana R, et al. (2016) Yes-associated protein mediates immune reprogramming in pancreatic ductal adenocarcinoma. Oncogene |
| Zhang YW, Nasto RE, Varghese R, et al. (2015) Acquisition of estrogen independence induces TOB1-related mechanisms supporting breast cancer cell proliferation. Oncogene |
| Zhu EF, Gai SA, Opel CF, et al. (2015) Synergistic innate and adaptive immune response to combination immunotherapy with anti-tumor antigen antibodies and extended serum half-life IL-2. Cancer Cell. 27: 489-501 |
| Zhang Y, Nasto RE, Varghese R, et al. (2015) Abstract 1716: Acquisition of estrogen independence induces TOB1-related mechanisms supporting breast cancer cell proliferation Cancer Research. 75: 1716-1716 |
| Surana R, Wang S, Xu W, et al. (2014) IL4 limits the efficacy of tumor-targeted antibody therapy in a murine model. Cancer Immunology Research. 2: 1103-12 |
| Shuptrine CW, Surana R, Weiner LM. (2012) Monoclonal antibodies for the treatment of cancer. Seminars in Cancer Biology. 22: 3-13 |
| Weiner LM, Surana R, Wang S. (2010) Monoclonal antibodies: versatile platforms for cancer immunotherapy. Nature Reviews. Immunology. 10: 317-27 |